Cromal 5 Inhaler

Sodium Cromoglycate (Cromoglicic acid)
Cipla Ltd.
Pack size
Dispensing mode
Source
Agent
Retail Price

Indications

Cromal 5 Inhaler is used for: Asthma, Asthma propylaxis

Adult Dose

Adults: Inhalation Asthma prophylaxis As dry powd/ nebulising soln: 20 mg 4 times/day As aerosol:10 mg 4 times/day, up to 6-8 times/day if needed, reduced to 5 mg 4 times/day once asthma has stabilised. Additional doses may be taken before exercise.

Child Dose

Renal Dose

Administration

Contra Indications

Hypersensitivity.

Precautions

Lactation, cardiac arrhythmias, hepatic or renal dysfunction.

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Sodium Cromoglycate (Cromoglicic acid) : Nausea, headache, dizziness, unpleasant taste, joint pain and swelling, skin rashes, aggravation of asthma, pulmonary infiltrates with eosinophilia, urticaria. Bronchospasm, wheezing, cough, nasal congestion and throat irritation following inhalation of dry powder.

Mechanism of Action

Sodium Cromoglycate inhibits degranulation of mast cells and therefore suppresses the release of histamine, leukotrienes and slow-reacting substance of anaphylaxis.

Note

Cromal 5 Inhaler manufactured by Cipla Ltd.. Its generic name is Sodium Cromoglycate (Cromoglicic acid). Cromal 5 is availble in Nepal. Farmaco Nepal drug index information on Cromal 5 Inhaler is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Sodium Cromoglycate (Cromoglicic acid) :